Assessing frailty in patients with acute stroke
Multimodal Assessment of Frailty in Acute Stroke Patients Treated at a Certified Stroke-unit
This study looks at how frailty affects recovery in people who have had an acute stroke to see what factors contribute to it and how it impacts their health over the next year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Giessen Academic / other |
| Locations | 1 site (Gießen, Hesse) |
| Trial ID | NCT06031909 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the prevalence and impact of frailty in patients who have experienced an acute stroke. It will analyze various factors contributing to frailty, including nutritional status, mobility impairments, and laboratory markers. The study will involve a multimodal frailty assessment to capture a comprehensive range of frailty characteristics and their effects on clinical outcomes. Patients will be followed for one year to evaluate the long-term implications of frailty on stroke recovery and complications.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with ischemic or hemorrhagic stroke who are treated at the certified stroke unit of the University Hospital Giessen.
Not a fit: Patients who withdraw care within 24 hours after admission will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of frailty in stroke patients, potentially enhancing their treatment outcomes.
How similar studies have performed: While frailty has been studied in various contexts, this specific multimodal assessment approach in acute stroke patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * treated at the certified stroke-unit of the Dpt. of Neurology, University Hospital Giessen * diagnosis of ischemic (including transient ischemic attack) or hemorrhagic stroke Exclusion Criteria: * withdrawal of care within 24 hours after admission
Where this trial is running
Gießen, Hesse
- Department of Neurology, University Hospital Giessen — Gießen, Hesse, Germany (Recruiting)
Study contacts
- Principal investigator: Stefan Gerner, MD — Department of Neurology, University Hospital Giessen/Germany
- Study coordinator: Stefan Gerner, MD
- Email: stefan.gerner@neuro.med.uni-giessen.de
- Phone: +49-641/985-45301
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.